First Tracks Biotherapeutics, Inc. (TRAX)
45.38
+1.90
(+4.38%)
USD |
NASDAQ |
Oct 27, 16:00
45.80
+0.42
(+0.91%)
After-Hours: 20:00
First Tracks Biotherapeutics Total Assets (Quarterly) : 183.14M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 183.14M |
| Date | Value |
|---|---|
| March 31, 2026 | 290.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AnaptysBio, Inc. | 346.01M |
| Mirum Pharmaceuticals, Inc. | 1.045B |
| Biogen, Inc. | 32.09B |
| Immunovant, Inc. | 852.49M |
| Forte Biosciences, Inc. | 205.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.34M |
| Shareholders Equity (Quarterly) | 168.80M |
| Debt to Equity Ratio | 0.0257 |
| Current Ratio | 14.28 |
| Net Debt Paydown Yield | -0.15% |